DA Davidson Maintains Neutral on Medifast, Lowers Price Target to $16.5
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
DA Davidson analyst Linda Bolton Weiser maintains Medifast (NYSE:MED) with a Neutral and lowers the price target from $17 to $16.5.
DA Davidson analyst Linda Bolton Weiser maintains Medifast (NYSE:MED) with a Neutral and lowers the price target from $17 to $16.5.